RECETA DE ANTIBIÓTICOS Y RESISTENCIA ANTIMICROBIANA
Lorem ipsum dolor sit amet In optio atque rem, quis similique ducimus hic cum eum
Lorem, ipsum dolor sit amet consectetur adipisicing elit. In optio atque rem, quis similique ducimus hic cum eum fugiat beatae dignissimos magni nihil libero blanditiis sapiente sint deleniti at illum!
Health Information and Quality Authority (HIQA), publicado en línea en abril de 2019
Esta evaluación de tecnología sanitaria (HTA) tuvo como objetivo establecer la rentabilidad clínica y económica del POCT de PCR, además de examinar las implicaciones organizativas de la posible introducción de la tecnología en la atención primaria. A continuación, se proporciona un resumen de los hallazgos clave:
La resistencia a los antimi...
Evaluación de tecnologías sanitarias de POCT de PCR para guiar las prescripciones de antibióticos para infecciones de las vías respiratorias en la ate...
European Network for Health Technology Assessment (EUnetHTA), publicado en línea en enero de 2019
Esta evaluación colaborativa sobre el análisis de diagnóstico inmediato (POCT) de la proteína C reactiva (PCR) tiene como objetivo guiar la prescripción de antibióticos en entornos de atención primaria para infecciones agudas de las vías respiratorias. La evaluación buscó responder tres preguntas mediante la realización de tres revisiones sis...
POCT de proteína C reactiva para guiar la prescripción de antibióticos en entornos de atención primaria para infecciones agudas de las vías respirator...
Jan Verbakel, Joseph Lee, Clare Goyder, Pui San Tan, Thanusha Ananthakumar, Philip Turner, Gail Hayward y Ann Van den Bruel
BMJ Open, 2019
El objetivo de esta revisión fue recopilar todas las pruebas disponibles del impacto de los análisis de diagnóstico inmediato (POCT) de la proteína C reactiva (PCR) sobre los resultados relevantes para los pacientes en niños y adultos en atención ambulatoria. Se incluyó un total de 11 ensayos control...
Impacto de las pruebas POC de PCR en la atención ambulatoria: una revisión sistemática y metaanálisis
One-size does not fit all across today's diverse and dynamic test settings. From antigen to molecular tests and various use cases, rapid test methods offer unique and overlapping utility, advantages, and disadvantages.
Expert perspectives on rapid point-of-care testing for respiratory infections
This updated guidance from the Infectious Diseases Society of America (IDSA) covers diagnosis,
treatment, chemoprophylaxis, and institutional outbreak management of seasonal influenza.
IDSA clinical practice guideline update on the management of seasonal influenza
Following 19 months of consultation, this report sets out the Review on Antimicrobial Resistance’s final recommendations to tackle antimicrobial resistance (AMR) globally, as commissioned by sponsors, the UK Government and the Wellcome Trust.
Tackling drug-resistant infections globally: report and recommendations
In our feature article series, we take a look at publications of particular relevance to point-of-care testing (POCT), providing summaries and expert commentary on the key aspects of the paper and within the wider context of POCT systems.In this article, we cover the below publication by Professor Cooke and co-authors
Respiratory tract infections in primary care: narrative review of CRP point-of-care testing and antibacterial use
The views and opinions presented are of the author only. The content contained in this podcast is intended for informational / educational purposes only.
Point-of-care testing for reducing risk and improving management of infectious diseases
The 31st European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) will bring together more than 14,000 attendees from all over the world, plus experts from relevant fields to present the latest findings and share their expertise.
European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
The World Anti-Microbial Resistance (AMR) congress is the world’s largest AMR congress, with approximately 800 attendees from across approximately 50 countries and more than 250 speakers.
The World Anti-Microbial Resistance (AMR) congress is the world’s largest AMR congress, with ~800 attendees from across ~50 countries and more than 250 speakers. This year, on 8–9 October 2020, myPOCacademy hosted a live seminar led by Professor Jonathan Cooke from Imperial College London and the University of Manchester (UK), now exclusively available to watch in full here.
Hear how point-of-care testing may aid in reducing antimicrobial resistance during the COVID-19 pandemic
The ERS international congress on 7–9 September 2020 delivered the latest innovations in respiratory medicine, plus offered an opportunity to interact and connect with the respiratory community virtually.
European Respiratory Society virtual international congress 2020
Check out the on-demand symposium recording from the European Respiratory Society congress 2020 by clicking here. Learn how C-reactive protein (CRP) point-of-care testing can be a valuable diagnostic and clinical decision-making tool in relation to COVID-19, and how it may also inform antibiotic prescribing for acutely exacerbated chronic obstructive pulmonary disease (COPD) patients.
Learn about the value of CRP point-of-care testing for COPD and antimicrobial resistance in the context of COVID-19
An international expert panel discusses POCT related to COVID-19 severity assessment and risk prediction, plus covers the role of POCT in antimicrobial resistance during the pandemic, in this video seminar originally delivered live on 9 September 2020. Hear from Professor Nicholas Francis (UK), Professor Ivan Gentile (Italy), Dr Carl Llor (Spain), Professor Dag Berild (Norway) and Dr Aggy York (UK) by clicking here.
Hear expert opinion on the use of CRP point-of-care testing for COVID-19 management and reduction of antimicrobial resistance
en
Acceder ya
Contenido Certificado
No hay más resultados
By using this site, you agree with our use of cookies.
